PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,265,898 | -30.6% | 2,929,903 | -11.9% | 0.09% | -32.3% |
| Q2 2023 | $43,604,712 | +26.5% | 3,326,065 | +7.9% | 0.13% | +21.5% |
| Q1 2023 | $34,470,735 | +131.9% | 3,083,250 | +74.9% | 0.11% | +109.8% |
| Q4 2022 | $14,865,108 | +69.4% | 1,763,358 | +234.7% | 0.05% | +45.7% |
| Q3 2022 | $8,776,000 | +51.5% | 526,797 | +33.8% | 0.04% | +45.8% |
| Q2 2022 | $5,794,000 | +236.5% | 393,600 | +467.1% | 0.02% | +242.9% |
| Q1 2022 | $1,722,000 | -83.1% | 69,400 | -78.2% | 0.01% | -82.9% |
| Q4 2021 | $10,195,000 | +12.8% | 317,907 | +26.6% | 0.04% | +2.5% |
| Q3 2021 | $9,038,000 | -69.0% | 251,200 | -62.0% | 0.04% | -69.5% |
| Q2 2021 | $29,155,000 | +95.3% | 660,801 | +102.5% | 0.13% | +87.1% |
| Q1 2021 | $14,926,000 | +165.0% | 326,313 | +299.9% | 0.07% | +159.3% |
| Q4 2020 | $5,632,000 | – | 81,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |